Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events.
about
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dimethyl fumarate: a possible ...... isk for severe adverse events.
@en
type
label
Dimethyl fumarate: a possible ...... isk for severe adverse events.
@en
prefLabel
Dimethyl fumarate: a possible ...... isk for severe adverse events.
@en
P2093
P356
P1476
Dimethyl fumarate: a possible ...... isk for severe adverse events.
@en
P2093
Albulena Bajrami
Gabriele Farina
Massimiliano Calabrese
Roberta Magliozzi
Salvatore Monaco
P304
P356
10.1136/JNNP-2017-316236
P407
P577
2017-08-26T00:00:00Z